期刊文献+

静脉注射丙种球蛋白无反应性川崎病的高危因素分析

Risk factors of children with Kawasaki disease resistant to intravenous immunoglobulin
下载PDF
导出
摘要 川崎病是一种好发于儿童的急性全身性血管炎性疾病。目前,大剂量静脉注射丙种球蛋白联合口服阿司匹林是川崎病的标准治疗方案,但临床上存在一部分对静脉注射丙种球蛋白不敏感的病例。此类患者容易形成冠状动脉动病变,严重时可能导致心肌梗死和死亡。本文主要综述静脉注射丙种球蛋白无反应性川崎病的相关高危因素。 Kawasaki disease is an acute systemic vasculitic disease that tends to occur in children.At present,high-dose intravenous immunoglobulin combined with oral aspirin is the standard treatment for Kawasaki disease,but some cases are not sensitive to intravenous immunoglobulin clinically.Such patients are prone to coronary artery lesions,which may lead to myocardial infarction and death in severe cases.This article mainly reviews the risk factors of children with Kawasaki disease resistant to intravenous immunoglobulin.
作者 杨成洋 范雪 徐明国 Yang Chengyang;Fan Xue;Xu Mingguo(Medical College,Shantou University,Shantou 515000,China)
机构地区 汕头大学医学院
出处 《国际医药卫生导报》 2023年第10期1358-1360,共3页 International Medicine and Health Guidance News
关键词 川崎病 高危因素 儿童 Kawasaki disease Risk factors Children
  • 相关文献

参考文献4

二级参考文献50

  • 1Ayuswa M,Sonobe T,Uemura S,et al.Revision of diagnostic guidelines for Kawasaki disease 5th edition[J].Pediatr Iht,2005,47(2):232-234.
  • 2Durongpisitkul K,Soongswang J,Laohaprasitiporn D,et al.Immunoglobulin failure and re-treatment in Kawasaki disease[J].Pediatr Cardiol,2003,24(2):145-148.
  • 3Uehara R,Belay ED,Maddox RA,et al.Analysis of potential risk factors ass ociated with nonres ponse to initial intravenous immunogl obulin treatment among Kawasaki disease patients in Japan[J].Pediatr Infect Dis J,2008,27(2):155-160.
  • 4Han RK,Silverman ED,Newman A,et al.Management and outcome of persistene or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease[J].Arch Pediatr Adolese Med,2000,154 (7):694-699.
  • 5Durongpisitkul K,Soongswang J,Laohaprasitiporn D,et al.Gammaglobulin failure and retreatment in Kawasaki disease[J].Pediatr Res,2003,53(1):180.
  • 6Hashino K, Ishii M, Iemura M, et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int, 2001,43:211-217.
  • 7Wright DA, Newburger JW, Baker A, et al. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr,1996,128:146-149.
  • 8Wallace CA, French JW, Kahn SJ, et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics, 2000,105:E78.
  • 9Brogan PA, Bose A, Burgner D, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child, 2002,86:286-290.
  • 10Fukunishi M, Kikkawa M, Hamana K,et al. Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr, 2000,137:172-176.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部